Skip to content
+49 (0) 3302 20 94 49 - 0Neuendorfstraße 23 b/d 16761 Hennigsdorf (Germany)info@pentracor.de
Facebook page opens in new windowTwitter page opens in new windowYouTube page opens in new window
Pentracor
PentracorPentracor
  • Home
  • Therapy
    • CRP apheresis
    • CRP adsorber
    • Range of Applications
    • Applying Centers
    • Specialist Information
    • Publications
  • Services
  • About us
    • About us
    • Career
    • Medical Advisory Board
    • Partners
    • Investors
    • Funding projects
  • Investor Relations
    • Investor Relations
    • Bond
    • Financial Publications
    • Financial Releases
    • Questions & Answers
  • News
    • News
    • Press Releases
    • Published Papers
    • Awards
    • Webinars
    • Events
    • Other
  • Contact
Book a visit
  • Home
  • Therapy
    • CRP apheresis
    • CRP adsorber
    • Range of Applications
    • Applying Centers
    • Specialist Information
    • Publications
  • Services
  • About us
    • About us
    • Career
    • Medical Advisory Board
    • Partners
    • Investors
    • Funding projects
  • Investor Relations
    • Investor Relations
    • Bond
    • Financial Publications
    • Financial Releases
    • Questions & Answers
  • News
    • News
    • Press Releases
    • Published Papers
    • Awards
    • Webinars
    • Events
    • Other
  • Contact

Archives: Fachpublikationen

You are here:
  1. Home
  2. news

Special Issue "C-Reactive Protein and Cardiovascular Disease: Clinical Aspects"

By fba18. July 2022

22.06.2022

This editorial was published in the Journal of Clinical Medicine.

New article on CRP apheresis in acute myocardial infarction or COVID-19 published

By abu15. July 2022

Berlin, 25.03.2022

The article appeared in the renowned magazine "Medical Clinic - Intensive Care Medicine and Emergency Medicine" in issue 117 on pages 191-199.

Another Publication on 7 COVID patients

By fba1. April 2022

01.04.2022

The Journal of Clinical Medicine published an article on 7 patients with severe COVID-19 who have been treated with CRP apheresis.

German Journal "Ärzteblatt" on C-reactive protein

By fba1. April 2022

01.04.2022

Today the north-eastern German journal reports on C-reactive protein

Review zur CRP-Apherese bei Herzinfarkt und COVID-19

By fba28. March 2022

28.03.2022

A German medical magazine for intensive care and emergency medicine published a review on CRP-Apheresis in patients with acute myocardial infarction and COVID-19

Publication on the pros and cons of CRP-Apheresis

By fba28. March 2022

28.03.2022

The Journal of Clinical Medicine published an article on the pros and cons of selective CRP-Apheresis in humans.

Case series reports treatment of seven COVID-19 patients with CRP apheresis

By abu4. March 2022

26.02.2022

The clinical observations of the article by Fabrizio Esposito, Harald Matthes and Friedemann Schad from the Havelhöhe Community Hospital in Berlin support the hypothesis that CRP is a possible therapeutic target in the treatment of early stages of severe COVID-19.

Article on CRP in cardiovascular events

By fba24. February 2022

17.02.2022

A recently published article in the Journal of Clinical Medicine shows the influence of high levels of CRP on G-protein coupled receptors (GPCRs).

American Journal of Case Reports: CRP apheresis in severe COVID-19

By fba7. January 2022

30.12.2021

"Most Viewed" article: A new case report from 7 patients suggests the effectiveness of CRP apheresis in severe COVID-19.

Another Case Report on CRP apheresis in COVID-19 published.

By fba6. August 2021

02.08.2021

Recently a new case report has been published in Frontiers in Immunology about the first COVID-19 patient at the onset of a severe COVID-19 course. Small heads-up: it turned out amazingly well!

123
Go to Top
en_GB
en_GB de_DE